Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). (3rd May 2022)

• Record Type: Journal Article
• Authors: Lane, Janet Athene; Donovan, Jenny L.; Young, Grace J.; Davis, Michael; Walsh, Eleanor I.; Avery, Kerry N.L.; Blazeby, Jane M.; Mason, Malcolm D.; Martin, Richard M.; Peters, Tim J.; Turner, Emma L.; Wade, Julia; Bollina, Prasad; Catto, James W.F.; Doherty, Alan; Gillatt, David; Gnanapragasam, Vincent; Hughes, Owen; Kockelbergh, Roger; Kynaston, Howard; Oxley, Jon; Paul, Alan; Paez, Edgar; Rosario, Derek J.; Rowe, Edward; Staffurth, John; Neal, David E.; Hamdy, Freddie C.; Metcalfe, Chris
• Other Names: Doble Andrew investigator.; Powell Philip investigator.; Prescott Stephen investigator.; Anderson John B. investigator.; Aning Jonathan investigator.; Durkan Garett investigator.; Kouparis Anthony investigator.; Leung Hing investigator.; Mariappan Param investigator.; McNeill Alan investigator.; Persad Raj investigator.; Schwaibold Hartwig investigator.; Tulloch David investigator.; Wallace Michael investigator.; Bonnington Susan investigator.; Bradshaw Lynne investigator.; Cooper Deborah investigator.; Elliott Emma investigator.; Herbert Phillipa investigator.; Holding Peter investigator.; Howson Joanne investigator.; Jones Amanda investigator.; Lennon Teresa investigator.; Lyons Norma investigator.; Moody Hilary investigator.; Plumb Claire investigator.; O'Sullivan Tricia investigator.; Salter Elizabeth investigator.; Thompson Pauline investigator.; Tidball Sarah investigator.; Blaikie Jan investigator.; Grey Catherine investigator.; Adam Tonia investigator.; Askew Sarah investigator.; Atkinson Sharon investigator.; Baynes Tim investigator.; Brain Carole investigator.; Breen Viv investigator.; Brunt Sarah investigator.; Bryne Sean investigator.; Bythem Jo investigator.; Clarke Jenny investigator.; Cloete Jenny investigator.; Dark Susan investigator.; Davis Gill investigator.; De La Rue Rachael investigator.; Denizot Jane investigator.; Dewhurst Elspeth investigator.; Dimes Anna investigator.; Dixon Nicola investigator.; Ebbs Penny investigator.; Emmerson Ingrid investigator.; Ferguson Jill investigator.; Gadd Ali investigator.; Geoghegan Lisa investigator.; Grant Alison investigator.; Grant Collette investigator.; Godfrey Rosemary investigator.; Goodwin Louise investigator.; Hall Susie investigator.; Hart Liz investigator.; Harvey Andrew investigator.; Hoult Chloe investigator.; Hawkins Sarah investigator.; Holling Sharon investigator.; Innes Alastair investigator.; Kilner Sue investigator.; Marshall Fiona investigator.; Mellen Louise investigator.; Moore Andrea investigator.; Napier Sally investigator.; Needham Julie investigator.; Pearse Kevin investigator.; Pisa Anna investigator.; Rees Mark investigator.; Richards Ellie investigator.; Robson Lindsay investigator.; Roxburgh Janet investigator.; Samuel Nikki investigator.; Sharkey Irene investigator.; Slater Michael investigator.; Smith Donna investigator.; Taggart Pippa investigator.; Taylor Helen investigator.; Taylor Vicky investigator.; Thomas Ayesha investigator.; Tomkies Briony investigator.; Trewick Nicola investigator.; Ward Claire investigator.; Walker Christy investigator.; Williams Ayesha investigator.; Woodhouse Colin investigator.; Wyber Elizabeth investigator.; Bahl Amit investigator.; Benson Richard investigator.; Beresford Mark investigator.; Ferguson Catherine investigator.; Graham John investigator.; Herbert Chris investigator.; Howard Grahame investigator.; James Nick investigator.; Kirkbride Peter investigator.; Law Alastair investigator.; Loughrey Carmel investigator.; McClaren Duncan investigator.; Patterson Helen investigator.; Pedley Ian investigator.; Roberts Trevor investigator.; Robinson Angus investigator.; Russell Simon investigator.; Symonds Paul investigator.; Thanvi Narottam investigator.; Vasanthan Subramaniam investigator.; Wilson Paula investigator.; Robinson Mary investigator.; Bhattarai Selina investigator.; Deshmukh Neeta investigator.; Dormer John investigator.; Fernando Malee investigator.; Goepel John investigator.; Griffiths David investigator.; Grigor Ken investigator.; Mayer Nick investigator.; Varma Murali investigator.; Warren Anne investigator.; Appleby Helen investigator.; Ash Dominic investigator.; Aston Dean investigator.; Bolton Steven investigator.; Chalmers Graham investigator.; Conway John investigator.; Early Nick investigator.; Geater Tony investigator.; Goddall Lynda investigator.; Heymann Claire investigator.; Hicks Deborah investigator.; Jones Liza investigator.; Lamb Susan investigator.; Lambert Geoff investigator.; Lawrence Gill investigator.; Lewis Geraint investigator.; Lilley John investigator.; MacLeod Aileen investigator.; Massey Pauline investigator.; McQueen Alison investigator.; Moore Rollo investigator.; Penketh Lynda investigator.; Potterton Janet investigator.; Roberts Neil investigator.; Showler Helen investigator.; Shuttleworth Pam investigator.; Slade Stephen investigator.; Steele Alasdair investigator.; Swinscoe James investigator.; Tiffany Marie investigator.; Townley John investigator.; Treeby Jo investigator.; Weston Michael investigator.; Wilkinson Joyce investigator.; Williams Lorraine investigator.; Wills Lucy investigator.; Woodley Owain investigator.; Yarrow Sue investigator.; Brindle Lucy investigator.; Davies Linda investigator.; Dedman Dan investigator.; Down Elizabeth investigator.; Khazragui Hanan investigator.; Noble Sian investigator.; Taylor Hilary investigator.; Tazewell Marta investigator.; Baker Susan investigator.; Bellis‐Sheldon Elizabeth investigator.; Bougard Chantal investigator.; Bowtell Joanne investigator.; Brewer Catherine investigator.; Burton Chris investigator.; Charlton Jennie investigator.; Christoforou Nicholas investigator.; Clark Rebecca investigator.; Coull Susan investigator.; Croker Christine investigator.; Currer Rosemary investigator.; Daisey Claire investigator.; Delaney Gill investigator.; Donohue Rose investigator.; Drew Jane investigator.; Farmer Rebecca investigator.; Fry Susan investigator.; Haddow Jean investigator.; Hale Alex investigator.; Halpin Susan investigator.; Harris Belle investigator.; Hattrick Barbara investigator.; Holmes Sharon investigator.; Hunt Helen investigator.; Jackson Vicky investigator.; Johnson Donna investigator.; Le Butt Mandy investigator.; Leworthy Jo investigator.; Liddiatt Tanya investigator.; Martin Alex investigator.; Mauree Jainee investigator.; Moore Susan investigator.; Moulam Gill investigator.; Mutch Jackie investigator.; Parker Kathleen investigator.; Pawsey Christopher investigator.; Purdie Michelle investigator.; Robson Teresa investigator.; Smith Lynne investigator.; Stenton Carole investigator.; Steuart‐Feilding Tom investigator.; Stott Beth investigator.; Sully Chris investigator.; Sutton Caroline investigator.; Torrington Carol investigator.; Wilkins Zoe investigator.; Williams Sharon investigator.; Wilson Andrea investigator.; Weaver Ashleigh investigator.; Albertsen Peter investigator.; Adolfsson Jan investigator.; Baum Michael investigator.; Koupparis Anthony investigator.; McFarlane Jon investigator.; Reid Colette investigator.; Robinson Mary investigator.; Zietman Anthony investigator.; Hill Elizabeth investigator.; Ng Siaw Yein investigator.; Williams Naomi investigator.; Toole Jessica investigator.; Davies Charlotte investigator.; Hughes Laura investigator.; Rowlands Mari‐Anne investigator.; Bell Lindsey investigator.; Harrison Sean investigator.; Grant Adrian investigator.; Roberts Ian investigator.; Ashby Deborah investigator.; Cowan Richard investigator.; Fayers Peter investigator.; Mellon Killian investigator.; N'Dow James investigator.; O'Brien Tim investigator.; Sokhal Michael investigator.; Dearnaley David investigator.; Schröder Fritz investigator.; Roberts Tracy investigator.;
• Is Part Of: BJU international. Volume 130:Number 3(2022)
• Page Start: 370
• Page End: 380
• Publication Date: 2022-05-03
• Subjects: localised prostate cancer -- treatments -- patient‐reported outcomes -- functional outcomes -- quality of life -- #PCSM -- #ProstateCancer -- #uroonc; Genitourinary organs -- Diseases -- Periodicals; Genitourinary organs -- Surgery -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1111/bju.15739
• Languages: English
• ISSNs: 1464-4096

Abstract

Abstract : Objective: To investigate the functional and quality of life (QoL) outcomes of treatments for localised prostate cancer and inform treatment decision‐making. Patients and Methods: Men aged 50–69 years diagnosed with localised prostate cancer by prostate‐specific antigen testing and biopsies at nine UK centres in the Prostate Testing for Cancer and Treatment (ProtecT) trial were randomised to, or chose one of, three treatments. Of 2565 participants, 1135 men received active monitoring (AM), 750 a radical prostatectomy (RP), 603 external‐beam radiotherapy (EBRT) with concurrent androgen‐deprivation therapy (ADT) and 77 low‐dose‐rate brachytherapy (BT, not a randomised treatment). Patient‐reported outcome measures (PROMs) completed annually for 6 years were analysed by initial treatment and censored for subsequent treatments. Mixed effects models were adjusted for baseline characteristics using propensity scores. Results: Treatment‐received analyses revealed different impacts of treatments over 6 years. Men remaining on AM experienced gradual declines in sexual and urinary function with age (e.g., increases in erectile dysfunction from 35% of men at baseline to 53% at 6 years and nocturia similarly from 20% to 38%). Radical treatment impacts were immediate and continued over 6 years. After RP, 95% of men reported erectile dysfunction persisting for 85% at 6 years, and after EBRT this was reported by 69% and 74%, respectively ( P < 0.001 compared with AM). After RP, 36% of men reported urinary leakage requiring at least 1 pad/day, persisting for 20% at 6 years, compared with no change in men receiving EBRT or AM ( P < 0.001). Worse bowel function and bother (e.g., bloody stools 6% at 6 years and faecal incontinence 10%) was experienced by men after EBRT than after RP or AM ( P < 0.001) with lesser effects after BT. No treatment affected mental or physical QoL. Conclusion: Treatment decision‐making for localised prostate cancer can be informed by these 6‐year functional and QoL outcomes.